1. Home
  2. CYBN vs MPAA Comparison

CYBN vs MPAA Comparison

Compare CYBN & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • MPAA
  • Stock Information
  • Founded
  • CYBN 2019
  • MPAA 1968
  • Country
  • CYBN Canada
  • MPAA United States
  • Employees
  • CYBN N/A
  • MPAA N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • MPAA Auto Parts:O.E.M.
  • Sector
  • CYBN Health Care
  • MPAA Consumer Discretionary
  • Exchange
  • CYBN Nasdaq
  • MPAA Nasdaq
  • Market Cap
  • CYBN 176.0M
  • MPAA 188.9M
  • IPO Year
  • CYBN N/A
  • MPAA 1994
  • Fundamental
  • Price
  • CYBN $7.11
  • MPAA $14.45
  • Analyst Decision
  • CYBN Strong Buy
  • MPAA
  • Analyst Count
  • CYBN 3
  • MPAA 0
  • Target Price
  • CYBN $85.00
  • MPAA N/A
  • AVG Volume (30 Days)
  • CYBN 351.0K
  • MPAA 189.8K
  • Earning Date
  • CYBN 08-13-2025
  • MPAA 08-11-2025
  • Dividend Yield
  • CYBN N/A
  • MPAA N/A
  • EPS Growth
  • CYBN N/A
  • MPAA N/A
  • EPS
  • CYBN N/A
  • MPAA 0.08
  • Revenue
  • CYBN N/A
  • MPAA $775,831,000.00
  • Revenue This Year
  • CYBN N/A
  • MPAA $7.74
  • Revenue Next Year
  • CYBN N/A
  • MPAA $5.00
  • P/E Ratio
  • CYBN N/A
  • MPAA $178.36
  • Revenue Growth
  • CYBN N/A
  • MPAA 6.59
  • 52 Week Low
  • CYBN $4.81
  • MPAA $5.16
  • 52 Week High
  • CYBN $13.88
  • MPAA $15.20
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.43
  • MPAA 67.96
  • Support Level
  • CYBN $6.36
  • MPAA $13.31
  • Resistance Level
  • CYBN $7.75
  • MPAA $14.13
  • Average True Range (ATR)
  • CYBN 0.34
  • MPAA 0.93
  • MACD
  • CYBN -0.04
  • MPAA 0.15
  • Stochastic Oscillator
  • CYBN 51.95
  • MPAA 84.96

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

Share on Social Networks: